How Does Your Hypothalamus and Progesterone Affect PMS?

How does your hypothalamus and progesterone affect PMS? Let’s talk about it. 

While 90% of women experience premenstrual symptoms, 20-40% experience premenstrual syndrome.

Your hypothalamus controls your ovarian production of hormones via the hypothalamic-pituitary-ovarian axis. If you have PMS, it’s very important that you support your hypothalamus. 

Premenstrual syndrome is characterized by excessive estrogen-dominant symptoms like bloating, breast tenderness, heavy menstrual periods, moodiness, depression, anxiety, irritability, as well as gastrointestinal symptoms, like.

Women experience PMS symptoms from two days before their period to a week or longer before their period and extending into the first couple days of their menstrual cycle.

Supporting your hypothalamus nutraceutically with Genesis Gold® can make a big difference in ameliorating your PMS symptoms. You will feel better balanced. If you’re not producing enough progesterone, taking supplemental progesterone can have a calming effect on your moods and help with estrogen dominance symptoms, calming down bloating and breast tenderness.

I have found that my patients with PMS do very well with Genesis Gold® for hypothalamus support and supplemental progesterone if necessary with Gen-Pro.

Gen-Pro is a prescription-grade transdermal progesterone I’ve been using with my patients for the last thirty years. For PMS, the dose is 50 to 100 milligrams twice a day in the luteal phase or a day or two before your expected symptoms. Some women find relief with Gen-Pro at the first sign of premenstrual symptoms. Gen-Pro has a calming effect on your moods and can be used as needed. 

The best place to apply transdermal progesterone is your inner thighs which are rich in highly vascular brown fat.

If you have any questions about PMS, your hypothalamus and progesterone, please join us in our Hormone Reboot Training.

Resources:

Progesterone Actions and Resistance in Gynecological Disorders; James A MacLean et al. Cells. 2022. Progesterone Actions and Resistance in Gynecological Disorders – PubMed